Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Löwer

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Biotechnology and Applied Biochemistry|January 16, 1999
Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coliH Braun, K Boller, J Löwer, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2007
Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disasterB Liedert, S Bassus, C K Schneider, et al.
Vox Sanguinis|January 9, 2008
The harmonization of the regulation of blood products: a European perspectiveR Seitz, M Heiden, C M Nübling, et al.
The Journal of Urology|November 1, 1982
Synthesis of retrovirus-like particles in testicular teratocarcinomasR Harzmann, J Löwer, R Löwer, et al.
Journal of Virology|January 1, 1995
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-KR Löwer, R R Tönjes, C Korbmacher, et al.
Developments in Biological Standardization|January 1, 1991
Epidemiology and pathogenicity of human retrovirusesR Kurth, M Baier, D Binninger, et al.
Journal of Virology|October 3, 2001
Rec (formerly Corf) function requires interaction with a complex, folded RNA structure within its responsive element rather than binding to a discrete specific binding siteC Magin-Lachmann, S Hahn, H Strobel, et al.
Klinische Wochenschrift|April 15, 1986
Detection of antibodies to HTLV-III in commercially available immunoglobulin preparationsR Kurth, I Schmidt, A Werner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1993
Identification of human endogenous retroviruses with complex mRNA expression and particle formationR Löwer, K Boller, B Hasenmaier, et al.
Virology|September 1, 1993
Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDVK Boller, H König, M Sauter, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Biotechnology and Applied Biochemistry|January 16, 1999
Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coliH Braun, K Boller, J Löwer, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2007
Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disasterB Liedert, S Bassus, C K Schneider, et al.
Vox Sanguinis|January 9, 2008
The harmonization of the regulation of blood products: a European perspectiveR Seitz, M Heiden, C M Nübling, et al.
The Journal of Urology|November 1, 1982
Synthesis of retrovirus-like particles in testicular teratocarcinomasR Harzmann, J Löwer, R Löwer, et al.
Journal of Virology|January 1, 1995
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-KR Löwer, R R Tönjes, C Korbmacher, et al.
Developments in Biological Standardization|January 1, 1991
Epidemiology and pathogenicity of human retrovirusesR Kurth, M Baier, D Binninger, et al.
Journal of Virology|October 3, 2001
Rec (formerly Corf) function requires interaction with a complex, folded RNA structure within its responsive element rather than binding to a discrete specific binding siteC Magin-Lachmann, S Hahn, H Strobel, et al.
Klinische Wochenschrift|April 15, 1986
Detection of antibodies to HTLV-III in commercially available immunoglobulin preparationsR Kurth, I Schmidt, A Werner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1993
Identification of human endogenous retroviruses with complex mRNA expression and particle formationR Löwer, K Boller, B Hasenmaier, et al.
Virology|September 1, 1993
Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDVK Boller, H König, M Sauter, et al.
Pageof 5